A regulatory circuit involving miR-143 and DNMT3a mediates vascular smooth muscle cell proliferation induced by homocysteine

Molecular Medicine Reports

Volumn 13, Issue 1, 2016, Pages 483-490

  Zhang, Hui Ping ^a   Wang, Yan Hua ^a   Cao, Cheng Jian ^b   Yang, Xiao Ming ^a   Ma, Sheng Chao ^b   Han, Xue Bo ^a   Yang, Xiao Ling ^a   Yang, An Ning ^b   Tian, Jue ^a   Xu, Hua ^a   Zhang, Ming Hao ^a   Jiang, Yi Deng ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

DNA methylation; DNA methyltransferase 3a; Homocysteine; MicroRNA 143; Vascular smooth muscle cell proliferation

Indexed keywords

DNA METHYLTRANSFERASE 3A; HOMOCYSTEINE; MICRORNA 143; DNA (CYTOSINE 5) METHYLTRANSFERASE; MICRORNA; MIRN143 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; CYTOLOGY; DNA METHYLATION; DRUG EFFECTS; ENZYMOLOGY; GENE REGULATORY NETWORK; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; GENE REGULATORY NETWORKS; HOMOCYSTEINE; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; UP-REGULATION;

EID: 84954206290     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4558     Document Type: Article

References (39)

1. van den Brandhof WE, Haks K, Schouten EG and Verhoef P: The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 157: 403-9, 2001.
2. Ozkan Y, Ozkan E and Simşek B: Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardio 82: 269-277, 2002.
3. Zhang D, Wen X, Wu W, Xu E, Zhang Y and Cui W: Homocysteine-related hTERT DNA demethylation contributes to shortened leukocyte telomere length in atherosclerosis. Atherosclerosis 231: 173-179, 2013.
4. Horvath B, Szapary L, Debreceni L, Feher G, Kenyeres P, Fulop A, Battyani I and Toth K: Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases. Clin Hemorheol Microcirc 42: 19-28, 2009.
5. Liang Y, Yang X, Ma L, Cai X, Wang L, Yang C, Li G, Zhang M, Sun W and Jiang Y: Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells. Acta Biochim Biophys Sin (Shanghai) 45: 220-228, 2013.
6. Jacob T, Hingorani A and Ascher E: Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions. Angiology 60: 562-568, 2009.
7. Kim Y, Han JH, Yun E, Jung SH, Lee JJ, Song GY and Myung CS: Inhibitory effect of a novel naphthoquinone derivative on proliferation of vascular smooth muscle cells through suppression of platelet-derived growth factor receptor β tyrosine kinase. Eur J Pharmacol 733: 81-89, 2014.
8. Huang J and Kontos CD: Inhibition of vascular smooth muscle cell proliferation, migration and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol 22: 745-751, 2002.
9. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K and Sueishi K: Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82: 147-156, 1998.
10. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Zhang C: MicroRNA and vascular smooth muscle cell phenotype: New therapy for atherosclerosis?. Genome Med 1: 85, 2009.
12. Rangrez AY, Massy ZA, Metzinger-Le Meuth V and Metzinger L: MiR-143 and miR-145: Molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4: 197-205, 2011.
13. Dong S, Xiong W, Yuan J, Li J, Liu J and Xu X: MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-κB expression. Mol Med Rep 8: 407-412, 2013.
14. Boucher JM, Peterson SM, Urs S, Zhang C and Liaw L: The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem 286: 28312-28321, 2011.
15. Saetrom P, Snøve O Jr and Rossi JJ: Epigenetics and microRNAs. Pediatr Res 61: 17R-23R, 2007.
16. Hutnick LK, Golshani P, Namihira M, Xue Z, Matynia A, Yang XW, Silva AJ, Schweizer FE and Fan G: DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum Mol Genet 18: 2875-2888, 2009.
17. Liu K, Wang YF, Cantemir C and Muller MT: Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2 and DNMT3 in mammalian cells in vivo. Mol Cell Biol 23: 2709-2719, 2003.
18. Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meissner A, Jenuwein T, Xu G, Leonhardt H, Wolf V and Walter J: In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLoS Genet 8: e1002750, 2012.
19. Krebs HA, Hems R and Tyler B: The regulation of folate and methionine metabolism. Biochem J 158: 341-353, 1976.
20. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y and Tokino T: Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132, 2008.
21. Veeck J and Esteller M: Breast cancer epigenetics: From DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 15: 5-17, 2010.
22. Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM and Klumb CE: Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. Exp Mol Pathol 98: 200-207, 2015.
23. Rao X, Huang X, Zhou Z and Lin X: An improvement of the 2(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3: 71-85, 2013.
24. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, Xiaoqun H and Shuren W: Homocysteine-mediated expression of SAHH, DNMTs, MBD2 and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 26: 603-611, 2007.
25. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Röcken C, Ebert MP, Kwok TT and Sung JJ: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706, 2009.
26. Pawlak K, Mysliwiec M and Pawlak D: Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis. Thromb Res 129:704-9, 2012.
27. Chistiakov DA, Orekhov AN and Bobryshev YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf) 214: 33-50, 2015.
28. Choe N, Kwon JS, Kim JR, Eom GH, Kim Y, Nam KI, Ahn Y, Kee HJ and Kook H: The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229: 348-355, 2013.
29. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G and Hata A: down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 286: 28097-28110, 2011.
30. Zhao W, Zhao SP and Zhao YH: MicroRNA-143/-145 in cardiovascular diseases. Biomed Res Int 2015: 531740, 2015.
31. Isa Y, Mishima T, Tsuge H and Hayakawa T: Increase in S-adenosylhomocysteine content and its effect on the S-adenosylhomocysteine hydrolase activity under transient high plasma homocysteine levels in rats. J Nutr Sci Vitaminol (Tokyo) 52: 479-482, 2006.
32. Smith DE, Smulders YM, Blom HJ, Popp J, Jessen F, Semmler A, Farkas M and Linnebank M: Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clin Chem Lab Med 50: 1641-1647, 2012.
33. Sandhu R, Rivenbark AG, Mackler RM, Livasy CA and Coleman WB: Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int J Oncol 44: 563-572, 2014.
34. Ma S, Zhang H, Sun W, Gong H, Wang Y, Ma C, Wang J, Cao C, Yang X, Tian J and Jiang Y: Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE(-/-) mice. Acta Biochim Biophys Sin (Shanghai) 45: 391-400, 2013.
35. Magdinier F, Billard LM, Wittmann G, Frappart L, Benchaïb M, Lenoir GM, Guérin JF and Dante R: Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J 14: 1585-1594, 2000.
36. He M, Fan J, Jiang R, Tang WX and Wang ZW: Expression of DNMTs and genomic DNA methylation in gastric signet ring cell carcinoma. Mol Med Rep 8: 942-948, 2013.
37. Holz-Schietinger C, Matje DM and Reich NO: Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation. J Biol Chem 287: 30941-30951, 2012.
38. Yu Z, Xiao Q, Zhao L, Ren J, Bai X, Sun M, Wu H, Liu X, Song Z, Yan Y, et al: DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis. Mol Carcinog, 2014
39. Sun X, He Y, Huang C, Ma TT and Li J: The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases. Cell Signal 25: 1870-1876, 2013.